Yamazaki Hideya (Hideya Yamazaki)

Scopus Author ID Researcher Name Resolver ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Topics

Radiation Therapy

Radical Prostatectomy

Prostate Cancer

Top Venues

Journal of clinical medicine

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Yamazaki Hideya, Gen Suzuki, Koji Masui, Kei Yamada, Takashi Ueda, Takumi Shiraishi, Atsuko Fujihara, Takashi Kato, Yasutoshi Hashimoto, Haruumi Okabe
Ultra-High Prostate-Specific Antigen Level: A Potential Very-High-Risk Factor for Localized High-Risk Prostate Cancer. Cancers 15 (23) (2023)
Yamazaki Hideya, Takuya Kimoto, Motohisa Suzuki, Masao Murakami, Osamu Suzuki, Masaru Takagi, Norio Katoh, Takeshi Arimura, Takashi Ogino, Hiroyuki Ogino
Particle Beam Therapy for Intrahepatic and Extrahepatic Biliary Duct Carcinoma: A Multi-Institutional Retrospective Data Analysis. Cancers 14 (23) (2022)
Yamazaki Hideya, Takuya Kimoto, Motohisa Suzuki, Masao Murakami, Osamu Suzuki, Masaru Takagi, Norio Katoh, Takeshi Arimura, Takashi Ogino, Hiroyuki Ogino
Particle Beam Therapy for Intrahepatic and Extrahepatic Biliary Duct Carcinoma: A Multi-Institutional Retrospective Data Analysis. Cancers 14 (23) (2022)
Yamazaki Hideya, Gen Suzuki, Koji Masui, Norihiro Aibe, Daisuke Shimizu, Takuya Kimoto, Kei Yamada, Koji Okihara, Takashi Ueda, Tsukasa Narukawa, Takumi Shiraishi, Atsuko Fujihara, Ken Yoshida, Satoaki Nakamura, Takashi Kato, Yasutoshi Hashimoto, Haruumi Okabe
Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b-4 and/or Gleason 9-10. Cancers 14 (12) (2022)
Yamazaki Hideya, Takuya Kimoto, Motohisa Suzuki, Masao Murakami, Osamu Suzuki, Masaru Takagi, Norio Katoh, Takeshi Arimura, Takashi Ogino, Hiroyuki Ogino
Particle Beam Therapy for Intrahepatic and Extrahepatic Biliary Duct Carcinoma: A Multi-Institutional Retrospective Data Analysis. Cancers 14 (23) (2022)
Yamazaki Hideya, Gen Suzuki, Norihiro Aibe, Daisuke Shimizu, Takuya Kimoto, Koji Masui, Ken Yoshida, Satoaki Nakamura, Yasutoshi Hashimoto, Haruumi Okabe
Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer. Cancers 14 (1) (2021)
Yamazaki Hideya, Gen Suzuki, Koji Masui, Norihiro Aibe, Daisuke Shimizu, Takuya Kimoto, Kei Yamada, Takumi Shiraishi, Atsuko Fujihara, Koji Okihara, Ken Yoshida, Satoaki Nakamura, Haruumi Okabe
Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors. Cancers 13 (14) (2021)
Shinsuke Nagasawa, Junko Takahashi, Gen Suzuki, Yamazaki Hideya, Kei Yamada
Why Concurrent CDDP and Radiotherapy Has Synergistic Antitumor Effects: A Review of In Vitro Experimental and Clinical-Based Studies. International journal of molecular sciences 22 (6) (2021)
Yamazaki Hideya, Gen Suzuki, Koji Masui, Norihiro Aibe, Daisuke Shimizu, Takuya Kimoto, Ken Yoshida, Satoaki Nakamura, Haruumi Okabe
Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy. Cancers 13 (8) (2021)
Yamazaki Hideya, Gen Suzuki, Norihiro Aibe, Satoaki Nakamura, Ken Yoshida
Fractionation or tumor factors-what matters in carotid blowout syndrome? Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 197 (8) (2021)
Yamazaki Hideya, Koji Masui, Gen Suzuki, Norihiro Aibe, Daisuke Shimizu, Takuya Kimoto, Ken Yoshida, Satoaki Nakamura
Potential Risk of Other-Cause Mortality Due to Long-Term Androgen Deprivation Therapy in Elderly Patients with Clinically Localized Prostate Cancer Treated with Radiotherapy-A Confirmation Study. Journal of clinical medicine 9 (7) (2020)
Yamazaki Hideya, Gen Suzuki, Tadashi Takenaka, Ken Yoshida
Is there clinical meaningful threshold in dose volume analysis between grade 0-2 and 3-4 radiation dermatitis? Head & neck 42 (8) (2020)
Yamazaki Hideya, Koji Masui, Gen Suzuki, Satoaki Nakamura, Norihiro Aibe, Daisuke Shimizu, Kei Yamada, Koji Okihara, Takumi Shiraishi, Tadayuki Kotsuma, Ken Yoshida, Eiichi Tanaka, Keisuke Otani, Yasuo Yoshioka, Kazuhiko Ogawa, Tatsuyuki Nishikawa, Haruumi Okabe
Effect of Androgen Deprivation Therapy on Other-Cause of Mortality in Elderly Patients with Clinically Localized Prostate Cancer Treated with Modern Radiotherapy: Is There a Negative Impact? Journal of clinical medicine 8 (3) (2019)
Yamazaki Hideya, Koji Masui, Gen Suzuki, Satoaki Nakamura, Daisuke Shimizu, Tatsuyuki Nishikawa, Haruumi Okabe, Ken Yoshida, Tadayuki Kotsuma, Eiichi Tanaka, Keisuke Otani, Yasuo Yoshioka, Kazuhiko Ogawa
High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer. Cancers 10 (9) (2018)
Yamazaki Hideya, Koji Masui, Gen Suzuki, Satoaki Nakamura, Norihiro Aibe, Daisuke Shimizu, Tatsuyuki Nishikawa, Haruumi Okabe, Ken Yoshida, Tadayuki Kotsuma, Eiichi Tanaka, Keisuke Otani, Yasuo Yoshioka, Kazuhiko Ogawa
Radiothrerapy for Elderly Patients Aged ≥75 Years with Clinically Localized Prostate Cancer-Is There a Role of Brachytherapy? Journal of clinical medicine 7 (11) (2018)